Medicalgorithmics Statistics

Total Valuation

Medicalgorithmics has a market cap or net worth of PLN 212.99 million. The enterprise value is 210.59 million.

Market Cap	212.99M
Enterprise Value	210.59M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Medicalgorithmics has 9.95 million shares outstanding. The number of shares has increased by 5.49% in one year.

Current Share Class	n/a
Shares Outstanding	9.95M
Shares Change (YoY)	+5.49%
Shares Change (QoQ)	+1.72%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	14.69%
Float	4.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.94
PB Ratio	2.63
P/TBV Ratio	17.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-17.37
EV / Sales	6.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.76

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.05.

Current Ratio	2.87
Quick Ratio	1.57
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -13.85% and return on invested capital (ROIC) is -8.35%.

Return on Equity (ROE)	-13.85%
Return on Assets (ROA)	-6.77%
Return on Invested Capital (ROIC)	-8.35%
Return on Capital Employed (ROCE)	-12.55%
Revenue Per Employee	255,617
Profits Per Employee	-101,033
Employee Count	120
Asset Turnover	0.27
Inventory Turnover	2.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.07% in the last 52 weeks. The beta is 0.98, so Medicalgorithmics's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-30.07%
50-Day Moving Average	18.67
200-Day Moving Average	23.82
Relative Strength Index (RSI)	63.21
Average Volume (20 Days)	36,812

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicalgorithmics had revenue of PLN 30.67 million and -12.12 million in losses. Loss per share was -1.22.

Revenue	30.67M
Gross Profit	3.98M
Operating Income	-12.37M
Pretax Income	-12.78M
Net Income	-12.12M
EBITDA	-11.86M
EBIT	-12.37M
Loss Per Share	-1.22

Full Income Statement

Balance Sheet

The company has 6.27 million in cash and 3.86 million in debt, giving a net cash position of 2.41 million or 0.24 per share.

Cash & Cash Equivalents	6.27M
Total Debt	3.86M
Net Cash	2.41M
Net Cash Per Share	0.24
Equity (Book Value)	81.12M
Book Value Per Share	8.15
Working Capital	15.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.30 million and capital expenditures -262,000, giving a free cash flow of -12.56 million.

Operating Cash Flow	-12.30M
Capital Expenditures	-262,000
Free Cash Flow	-12.56M
FCF Per Share	-1.26

Full Cash Flow Statement

Margins

Gross margin is 12.97%, with operating and profit margins of -40.32% and -39.53%.

Gross Margin	12.97%
Operating Margin	-40.32%
Pretax Margin	-41.66%
Profit Margin	-39.53%
EBITDA Margin	-38.66%
EBIT Margin	-40.32%
FCF Margin	n/a

Dividends & Yields

Medicalgorithmics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.49%
Shareholder Yield	-5.49%
Earnings Yield	-5.69%
FCF Yield	-5.90%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicalgorithmics has an Altman Z-Score of 4.85.

Altman Z-Score	4.85
Piotroski F-Score	n/a